Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page for the study now shows a 403 Forbidden error instead of the study details, indicating access restriction to the record and preventing viewing its information.
    Difference
    18%
    Check dated 2026-09-20T20:31:35.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study's Israel location list was updated to add Tel Litwinsky and remove Qiryat Krinitzi, altering the set of participating sites. Additionally, Melanoma and the MedlinePlus Genetics related topic were added to the page's topics.
    Difference
    0.1%
    Check dated 2026-09-13T19:26:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A new recruitment site in Qiryat Krinitzi, Israel, 52621 was added to the study's locations, expanding where participants can enroll. The Melanoma entry, related topics header, MedlinePlus Genetics link, and the Tel Litwinsky, Israel site were removed from the page.
    Difference
    0.1%
    Check dated 2026-09-06T22:27:00.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now includes a 2016 U.S. NIH grant/contract attribution. The release revision has been updated to Revision: v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T22:21:53.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    New related-topic entries were added for Melanoma and MedlinePlus Genetics. These appear under a related topics section to aid context and navigation.
    Difference
    0.1%
    Check dated 2026-08-23T21:51:22.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Three items were removed from the Related topics section: Melanoma, related topics:, and MedlinePlus Genetics. This reduces the set of related topic links shown on the study page.
    Difference
    0.1%
    Check dated 2026-08-16T21:56:34.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.